You Searched For: 4-Nitrophenyl-beta-D-xylopyranoside
6 057 results were found
BRLSPIMMUNOSURF 170518 Imm SurfaceMatters
/m-it.vwr.com/it_IT/images/BRLSPIMMUNOSURF_170518_Imm_SurfaceMatters.pdf
Thermo Scientific Immunoassay Plate Guide • Passive binding of biomacromolecules • Covalent coupling of smaller biomolecules • Capture of affinity-tagged biomolecules The right surface for your assay 2 Well configuration Advanced immunoassay surfa...
PG1702-PJT2232-COL05448-Protein-Quantification-TechNote-Gobal.indd
/m-sk.vwr.com/sk_SK/images/Protein-Quantification-TechNote.pdf
PG1702-PJT2232-COL05448-Protein-Quantification-TechNote-Gobal.indd TECHNICAL NOTE NanoDrop One/OneC and Multiskan Sky spectrophotometers A theoretical and practical guide for spectrophotometric determination of protein concentrations at 280 nm of ...
Upstream processing
/cms/bioprocessing_vaccines_upstream_processing
Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines, optimal production is achieved in mammal...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for mAbs
/cms/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/it/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/fr/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for mAbs
/cms/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
129 - 144 of 6 057